XML 47 R36.htm IDEA: XBRL DOCUMENT v3.24.1
Restatement of Previously Issued Financial Statements (Details) - USD ($)
$ in Thousands
1 Months Ended 2 Months Ended 3 Months Ended 6 Months Ended 7 Months Ended 9 Months Ended
Jul. 21, 2023
Sep. 30, 2023
Sep. 30, 2022
Jun. 30, 2023
Jul. 21, 2023
Sep. 30, 2022
Dec. 31, 2022
Restatement of Previously Issued Financial Statements              
Contingent consideration liability   $ 81,161          
Change in fair value of contingent consideration   (75,939)          
Additional paid-in capital   379,669         $ 187,348
Change in fair value of derivatives $ 11,789 15,776     $ 11,789    
Change in fair value of convertible notes (13,249)   $ (666)   (19,359) $ 15,261  
Adjustment              
Restatement of Previously Issued Financial Statements              
Contingent consideration liability   6,656          
Change in fair value of contingent consideration   (6,224)          
Additional paid-in capital   17,555          
Change in fair value of derivatives 6,830       6,830    
Change in fair value of convertible notes (15,831)       $ (15,831)    
Contingent Consideration Liability | Adjustment              
Restatement of Previously Issued Financial Statements              
Contingent consideration liability   6,700          
Change in fair value of contingent consideration   6,200          
Additional paid-in capital   12,900          
Derivative liabilities | Adjustment              
Restatement of Previously Issued Financial Statements              
Change in fair value of derivatives 6,800     $ 6,800      
Convertible notes | Adjustment              
Restatement of Previously Issued Financial Statements              
Change in fair value of convertible notes $ 15,800     $ 15,800      
Fair value measurement of stock options replaced in the Merger | Adjustment              
Restatement of Previously Issued Financial Statements              
Asset acquisition purchase price   2,700          
Share-based compensation expense   200          
Stock-based compensation recorded for the Founders Shares | Adjustment              
Restatement of Previously Issued Financial Statements              
Shares issued for Committed Financing   34,600          
Asset acquisition purchase price | Adjustment              
Restatement of Previously Issued Financial Statements              
Asset acquisition purchase price   24,100          
Fair value measurement of stock options replaced in the Merger and asset acquisition purchase price | Adjustment              
Restatement of Previously Issued Financial Statements              
Asset acquisition purchase price   26,800          
Acquired in-process research and development   24,000          
Loss on consolidation of VIE   $ 2,800